Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neoplasms, Second Primary × Thalidomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Waldenstrom Macroglobulinemia 1 Stomach Neoplasms 1 Neoplasms, Second Primary 1 Neoplasms 1 NSCLC 1 Multiple Myeloma 1 Immunoglobulin Light-chain Amyloidosis 1

Interventions

sacubitril and valsartan sodium hydrate drug combination 1 icotinib 1 Thalidomide 1 Megestrol Acetate 1 Isotretinoin 1 Drug Therapy 1 Doxycycline 1 Docetaxel 1 Carboplatin 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03777930 2018-12-19

The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol

Shenzhen Fifth People's Hospital

Phase 4 Unknown

Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡